Pharmaxis Quote - PXS

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.027

Bid

0.026

Ask

0.027

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

32.239M

Previous Close

0.027

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

0.00

Shares Outstanding

1,194,032,000

Dividend Yield

PE Ratio

-6.14

Earnings Per Share (EPS)

-0.01

Revenue

Net Profit

-13.67M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.pharmaxis.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

Pharmaxis Ltd is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker PXS. The last closing price for Pharmaxis was AUD0.03. Over the last year, Pharmaxis shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Pharmaxis currently has 1,194,032,000 shares outstanding. The market capitalization of Pharmaxis is AUD32.24 million. Pharmaxis has a price to earnings ratio (PE ratio) of -6.14.

FDA Bronchitol Approval to Generate Cash Flows for Pharmaxis

It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug Administration (FDA) of a medicine you have...

Here’s why Pharmaxis Ltd. shares are soaring today

http://www.fool.com.au/2015/03/12/heres-why-pharmaxis-ltd-shares-are-soaring-today/

NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients

NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic...

Pharmaxis Receives Approval to Market Bronchitol in the EU

Pharmaxis Receives Approval to Market Bronchitol in the EU PR Newswire ELTVILLE, Germany, April 27, 2012 ELTVILLE, Germany, April 27, 2012 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX:...

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code J7665 mannitol administered through inhaler PR Newswire EXTON, Pa., Jan. 3, 2012 EXTON, Pa., Jan. 3...

Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit

Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit ARIDOL is the Only Dry Powder Bronchial Challenge Test Approved for Use in the U.S. PR...

Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, October 26, 2011 SYDNEY, October 26, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis...

Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

Pharmaceutical company Pharmaxis (ASX: PXS) today announced the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of...

Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, Oct. 24, 2011 SYDNEY, Oct. 24, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX: PXS...

CHMP Recommends Marketing Authorization For Trajenta, Votubia

The Committee for Medicinal Products for Human Use, or CHMP, said Friday that it has adopted positive opinions recommending the granting of marketing authorizations for Trajenta-linagliptin, from...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	-0.083	-75.4545454545	0.11	0.11	0.0265	405158	0.06204357	DE
260	-0.103	-79.2307692308	0.13	0.17	0.0265	778017	0.08822842	DE

PXS - Frequently Asked Questions (FAQ)

What is the current Pharmaxis share price?

The current share price of Pharmaxis is AUD 0.027

How many Pharmaxis shares are in issue?

Pharmaxis has 1,194,032,000 shares in issue

What is the market cap of Pharmaxis?

The market capitalisation of Pharmaxis is AUD 32.24M

What is the 1 year trading range for Pharmaxis share price?

Pharmaxis has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Pharmaxis?

The price to earnings ratio of Pharmaxis is -6.14

What is the reporting currency for Pharmaxis?

Pharmaxis reports financial results in AUD

What is the latest annual profit for Pharmaxis?

The latest annual profit of Pharmaxis is AUD -13.67M

What is the registered address of Pharmaxis?

The registered address for Pharmaxis is 20 RODBOROUGH ROAD, FRENCHS FOREST, SYDNEY, NEW SOUTH WALES, 2086

What is the Pharmaxis website address?

The website address for Pharmaxis is www.pharmaxis.com.au

Which industry sector does Pharmaxis operate in?

Pharmaxis operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CDXOACardieX Limited	AUD 0.03 (76.47%)	2.19M
AQNAquirian Limited	AUD 0.295 (63.89%)	1.08M
CUFOCuFe Ltd	AUD 0.003 (50.00%)	301k
AQDAusquest Limited	AUD 0.033 (50.00%)	54.32M
LYNLycaon Resources Ltd	AUD 0.245 (48.48%)	642.61k
RADORadiopharm Theranostics Ltd	AUD 0.002 (-50.00%)	327.64k
RPMORPM Automotive Group Limited	AUD 0.002 (-50.00%)	2.21M
NHEONoble Helium Ltd	AUD 0.001 (-50.00%)	20k
PRSOAProspech Limited	AUD 0.001 (-50.00%)	66.67k
HFYHubify Limited	AUD 0.007 (-36.36%)	13.82M
ATHOAlterity Therapeutics Limited	AUD 0.004 (0.00%)	86.56M
AQDAusquest Limited	AUD 0.033 (50.00%)	54.32M
SYASayona Mining Limited	AUD 0.023 (-4.17%)	41.31M
BTRBrightstar Resources Limited	AUD 0.021 (0.00%)	36.06M
TMKTMK Energy Ltd	AUD 0.0025 (0.00%)	32.33M